<DOC>
	<DOC>NCT01863368</DOC>
	<brief_summary>The purpose of this study is to compare Systane® ULTRA lubricant eye drops to OPTIVE® lubricating eye drops for ocular surface staining within dry eye subjects and to evaluate the safety of Systane® ULTRA after 3 months of use.</brief_summary>
	<brief_title>Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining</brief_title>
	<detailed_description>Following a 2-week washout phase with saline eye drops, subjects were randomized to receive either Systane® ULTRA or OPTIVE® for the remainder of the study.</detailed_description>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Willing and able to attend all study visits. Diagnosis of dry eye, as specified in protocol. Uses artificial tears, as specified in protocol. Other protocoldefined inclusion criteria may apply. Poor visual acuity, as specified in protocol. Women of childbearing potential who are pregnant, lactating, or not using adequate birth control, as specified in protocol. Any hypersensitivity or allergy to the investigational products or ingredients. Any eye disorder, ocular surgery, medication, medical condition, or systemic disease, as specified in protocol. Contact lens use within 2 weeks of Screening Visit. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Dry eye syndrome</keyword>
	<keyword>Systane Ultra</keyword>
	<keyword>Optive</keyword>
	<keyword>Ocular Surface Staining</keyword>
	<keyword>OSDI</keyword>
	<keyword>Eye drops</keyword>
</DOC>